Department of Neurosurgery, Osaka Mishima Emergency Critical Care Center, Takatsuki, Japan.
Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Neurosurgery. 2023 Aug 1;93(2):309-319. doi: 10.1227/neu.0000000000002410. Epub 2023 Feb 24.
There is considerable debate regarding the definition of grade V subarachnoid hemorrhage (SAH). Recently, the Glasgow Coma Scale-Pupil (GCS-P) score was advocated for assessing traumatic brain injury.
To study the significance of pupillary findings and GCS-P in the management and outcomes of the World Federation of Neurological Societies (WFNS) grade V SAH.
We analyzed data obtained from a Japanese nationwide prospective registration study on the modified WFNS SAH grading system. Bilateral pupillary dilatation without reactivity was defined as pupil score 2, unilateral pupil dilation without reactivity as score 1, and no pupil dilatation with reactivity as score 0. The GCS-P score was calculated by subtracting the pupil score from the total GCS score. The characteristics and pupillary findings were examined in patients with each GCS score in WFNS grade V.
Among 1638 patients, 472 (men/women = 161/311, age 67.0 ± 14.0 years) had a GCS score of ≤6 after initial resuscitation on arrival. Overall, lower GCS scores were associated with poorer neurological outcomes and higher mortality. Aneurysms were treated in 20.5%, 53.9%, and 67.5% of patients with pupil scores of 2, 1, and 0, respectively. Favorable outcomes (modified Rankin Scale 0-2) at 3 months occurred in 4.5%, 10.8%, and 21.4% in patients with pupil scores 2, 1, and 0, respectively ( P < .0001), and in 0%, 0%, 13.6%, 28.6%, 16.7%, and 18.8% of patients with GCS-P scores 1 to 6 ( P < .0001), respectively.
Our study confirmed the significance of pupillary findings in decision making and outcomes of WFNS grade V SAH.
关于 5 级蛛网膜下腔出血(SAH)的定义存在很多争议。最近,格拉斯哥昏迷-瞳孔(GCS-P)评分被用于评估创伤性脑损伤。
研究瞳孔变化和 GCS-P 在世界神经外科联合会(WFNS)5 级 SAH 管理和结局中的意义。
我们分析了一项日本全国性前瞻性 WFNS 改良 SAH 分级系统注册研究的数据。双侧瞳孔无反应性扩张定义为瞳孔评分 2,单侧瞳孔扩张无反应性定义为评分 1,无瞳孔扩张有反应性定义为评分 0。GCS-P 评分通过从总 GCS 评分中减去瞳孔评分计算得出。在 WFNS 5 级中,根据每个 GCS 评分,检查患者的特征和瞳孔表现。
在 1638 例患者中,472 例(男性/女性=161/311,年龄 67.0±14.0 岁)在到达时初始复苏后 GCS 评分为≤6。总体而言,较低的 GCS 评分与较差的神经功能结局和较高的死亡率相关。瞳孔评分 2、1 和 0 的患者中,分别有 20.5%、53.9%和 67.5%接受了动脉瘤治疗。瞳孔评分 2、1 和 0 的患者中,3 个月时预后良好(改良 Rankin 量表 0-2)的比例分别为 4.5%、10.8%和 21.4%(P<0.0001),而 GCS-P 评分 1 至 6 的患者中,分别为 0%、0%、13.6%、28.6%、16.7%和 18.8%(P<0.0001)。
我们的研究证实了瞳孔表现对 WFNS 5 级 SAH 决策和结局的重要性。